Board of Directors

Ron Williams is co-founder of agilon health and has served as a director and chairman of the board since 2017. Mr. Williams also is Chairman and CEO of RW2 Enterprises, an Operating Advisor to private equity firm Clayton Dubilier & Rice (CD&R), and Chairman of apree health (previously Castlight/Vera Whole Health). He currently serves as Chairman of the Nominating and Governance Committee for Boeing and Director at Warby Parker. Mr. Williams previously served as Lead Director of American Express, Chair of the Compensation Committee for Johnson & Johnson, and the Chairman of naviHealth and PharMedium. Mr. Williams also served on the Board of Envision Healthcare from May 2011 to October 2017.

Mr. Williams joined Aetna in 2001 and was named President in 2002. He served as CEO and Chairman of the Board of Aetna from 2006 to 2010 and Chairman until his retirement in 2011.

Mr. Williams serves as Chairman of The Conference Board and the Peterson Institute for International Economics. He is a member of the President’s Circle of the National Academies. He was elected to the American Academy of Arts and Sciences and is a trustee of the Committee for Economic Development. He served on President Obama’s President’s Management Advisory Board from 2011 to 2017. Mr. Williams received his B.A. from Roosevelt University and holds an M.S. in Management from MIT Sloan School of Management.

Ravi Sachdev has served as a director of agilon health since 2017. Mr. Sachdev also serves as a director of Covetrus, Inc. and Steve Madden, Inc. As a Partner of CD&R since June 2015, Mr. Sachdev focuses on the healthcare sector. From November 2010 to May 2015, Mr. Sachdev was a Managing Director and Co-Head of Healthcare Services at J.P. Morgan Chase & Co. Prior to November 2010, Mr. Sachdev held the positions of Managing Director at Deutsche Bank Securities, Inc. from January 2009 until November 2010 and Director at Deutsche Bank AG from January 2007 until January 2009. Prior to joining Deutsche Bank AG in 2006 as a Vice President, Mr. Sachdev served as a Vice President at Peter J. Solomon Company, an investment banking firm, specializing in mergers and acquisitions in the healthcare sector, from 1998 to 2006. Mr. Sachdev received his B.A. from the University of Michigan.

Sharad Mansukani, M.D. has served as a director of agilon health since 2017. Dr. Mansukani also serves as a Senior Advisor to TPG, Children’s Hospital of Philadelphia, and Convey Health Solutions. Dr. Mansukani served as Chairman of the board of directors to Envision Rx Options from 2013 to 2016; a strategic advisor to the board of directors at Cigna Corp. from 2012 to 2015; Vice Chairman, Board of Directors of Health Spring, Inc. from 2007 to 2012; a director of IMS Health Holdings, Inc. from 2009 to 2016; a director of Surgical Care Affiliates, Inc. from 2007 to 2017; as lead director of IASIS Healthcare from 2005 to 2018; and a director of Kindred Healthcare, Inc. from 2015 to 2018. Dr. Mansukani also has served as a Senior Advisor on Medicare’s Program Advisory and Oversight Committee to the Secretary of the Department of Health and Human Services; Senior Advisor to the Administrator of the Centers for Medicare and Medicaid Services; and senior vice president and chief medical officer at Health Partners. Dr. Mansukani completed a residency and fellowship in ophthalmology at the University of Pennsylvania School of Medicine and a fellowship in quality management and managed care at the Wharton School of the University of Pennsylvania. He is a graduate of the Managed Care Executive Program at the Kellogg School of Business.

Diana L. McKenzie joined the agilon health board of directors in February 2023. Diana is a technology advisor, board member, and former Chief Information Officer with over thirty years of leadership experience gained from growing, scaling, and transforming global businesses in the Life Sciences and Software Industry with revenues ranging from $3-20B. She served as Workday’s first Chief Information Officer from 2016 to 2019. Before Workday, Diana served in multiple technology leadership roles at Amgen, Inc. from 2004-2016, including the role of Chief Information Officer. Prior to joining Amgen, she served in various technology leadership roles from 1987 to 2004 at Eli Lilly and Company.

Diana serves on MetLife, Inc., Vertex Pharmaceuticals, and Paradox boards and as a Special Advisor to Brighton Park Capital. She received her B.S. degree from Purdue University in 1986.

Karen McLoughlin joined the agilon health board of directors in July 2021. Ms. McLoughlin was the Chief Financial Officer of Cognizant Technology Solutions (“Cognizant”) from 2012 to 2020. Prior to joining Cognizant in 2003, Ms. McLoughlin was Vice President, Finance at Spherion from 1997 to 2003, Director, Corporate Accounting at Ryder Systems, Inc. from 1994 to 1997, and Manager, Middle Market Group at Price Waterhouse (which is now known as PricewaterhouseCoopers) from 1988 to 1994. Ms. McLoughlin currently serves on the board of directors of Best Buy as a member of the audit committee and chair of the finance and investment policy committee. Ms. McLoughlin received her B.A. from Wellesley College and her MBA from Columbia University.

Clay Richards joined the agilon health board of directors in Jan 2021. Clay is Co-Founder and Chief Executive Officer of naviHealth; Clay has responsibility for the organization's strategic vision and leadership. Richards spent most of his career in health care, where he most recently served in executive roles at Healthways, Inc. prior to founding naviHealth. He is active in the community and serves on the board of the Martha O'Bryan Center, which empowers children, youth, and adults in poverty to transform their lives, and on the Oak Hill School Board, as well as the Nashville Health Care Council Board and Vanderbilt Owen Graduate School Board of Visitors.

Richard Schnall has served as a director of agilon health since 2017. Mr. Schnall also serves as co-President of CD&R and on the board of directors of SmileDirectClub, Inc., as well as on the board of directors of Carestream Dental LLC, DeVilbiss Healthcare LLC and Healogics, Inc. Mr. Schall previously served on the board of directors of US Foods and Envision Healthcare. Mr. Schnall worked in the investment banking divisions of Smith Barney & Co. and Donaldson, Lufkin & Jenrette from 1992 to 1996. Mr. Schnall is a graduate of the University of Pennsylvania’s Wharton School and holds an MBA from Harvard Business School.

Steve Sell has served as our Chief Executive Officer and President and director since June 2020. In addition to his current role as Chief Executive Officer and President and director of agilon health, Steve also serves as an advisor to several early-stage healthcare companies. Steve served as President, CEO and Chairman of Health Net from March 2016 to June 2019 and President, Western Region of Health Net from November 2008 to March 2016. Steve received his B.A. from Swarthmore College and holds an MBA from the Stanford Graduate School of Business.

Derek Strum has served as a director of agilon health since 2017. Mr. Strum also serves as a partner at CD&R, and on the board of directors of Carestream Dental, Cynosure, Digestive Disease Research Foundation, Drive DeVilbiss Healthcare and Healogics. Previously, Mr. Strum worked in the investment banking division of Morgan Stanley from 2000 to 2003, and at York Capital Management, a multi-strategy investment firm, during the summer of 2006. Mr. Strum received his B.A. from Emory University and holds an MBA from Columbia Business School.

William Wulf, M.D. has served as a director of agilon health since 2017. In addition to his role as director of agilon health, Dr. Wulf is the CEO of Central Ohio Primary Care. COPC is one of our physician group partners. Dr. Wulf was a founding partner of COPC in 1996 and assumed the role of CEO in 2013 after 25 years as a practicing Internist and the Corporate Medical Director. Dr. Wulf has also served as an advisor for multiple payors, including Anthem, Aetna and United Healthcare. Dr. Wulf received his BS from 143 Ohio State University and his M.D. from the Medical College of Ohio in Toledo.

Jeff Schwaneke joined the agilon health board of directors in August 2022.  Jeff is the former Executive Vice President, Health Care Enterprises for Centene Corporation.

At Centene, Jeff held numerous positions and was instrumental in raising capital as well as leading seamless acquisitions. In his most recent role as EVP, Health Care Enterprises, Jeff oversaw Centene’s $35 billion pharmacy business including part D Medicare, dental and vision companies, and company-owned clinics. Prior to this role, Jeff served as Chief Financial Officer and Treasurer from 2016 to 2021; during his tenure, revenues grew from $20 billion to $125 billion. Jeff joined Centene in 2008 as Corporate Controller and Chief Accounting Officer.

Prior to joining Centene, Jeff served as the Assistant Controller and then as Chief Accounting Officer of Novelis, Inc., and he has held finance and accounting positions at SPX Corporation and PriceWaterhouse Coopers.

Jeff obtained his Bachelor’s degree in Accounting from the University of Missouri and is a CPA.